APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cold and Flu Supplement

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cold and Flu Supplement Market Outlook and Growth Opportunities 2026

Report ID 173979390420 December 2025190 pages

Choose your research edition.

Industry ResearchCold and Flu Supplement Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Cold and Flu Supplement Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Cold and Flu Supplement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cold and Flu Supplement Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cold and Flu Supplement Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Cold and Flu Supplement market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cold and Flu Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cold and Flu Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cold and Flu Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cold and Flu Supplement market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cold and Flu Supplement market include Pfizer, GlaxoSmithKline, Wakunaga of America, The Vitamin Shoppe, NOW Foods, Nordic Naturals, Neurobiologix, Klaire Labs and Himalaya Global Holdings, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cold and Flu Supplement market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cold and Flu Supplement and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cold and Flu Supplement revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cold and Flu Supplement market.

Cold and Flu Supplement Segment by Company

Pfizer

GlaxoSmithKline

Wakunaga of America

The Vitamin Shoppe

NOW Foods

Nordic Naturals

Neurobiologix

Klaire Labs

Himalaya Global Holdings

Flora

FineVine

Dr. Willmar Schwabe GmbH

Cold and Flu Supplement Segment by Type

Herbal Extracts

Natural Molecules

Vitamins and Minerals

Others

Cold and Flu Supplement Segment by Application

Online

Offline

Cold and Flu Supplement Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Cold and Flu Supplement status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cold and Flu Supplement key companies, revenue, market share, and recent developments.

3. To split the Cold and Flu Supplement breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cold and Flu Supplement market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cold and Flu Supplement significant trends, drivers, influence factors in global and regions.

6. To analyze Cold and Flu Supplement competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cold and Flu Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cold and Flu Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cold and Flu Supplement.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cold and Flu Supplement industry.

Chapter 3: Detailed analysis of Cold and Flu Supplement company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cold and Flu Supplement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cold and Flu Supplement in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cold and Flu Supplement Industry Trends Table 2. Cold and Flu Supplement Industry Drivers Table 3. Cold and Flu Supplement Industry Opportunities and Challenges Table 4. Cold and Flu Supplement Industry Restraints Table 5. Global Cold and Flu Supplement Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cold and Flu Supplement Revenue Share by Company (2021-2026) Table 7. Global Cold and Flu Supplement Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cold and Flu Supplement Key Company Manufacturing Base & Headquarters Table 9. Global Cold and Flu Supplement Company, Product Type & Application Table 10. Global Cold and Flu Supplement Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cold and Flu Supplement by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Herbal Extracts Table 15. Significant Companies of Natural Molecules Table 16. Significant Companies of Vitamins and Minerals Table 17. Significant Companies of Others Table 18. Global Cold and Flu Supplement Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Cold and Flu Supplement Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Cold and Flu Supplement Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Cold and Flu Supplement Sales Value Share by Type (2021-2026) Table 22. Global Cold and Flu Supplement Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Online Table 24. Significant Companies of Offline Table 25. Global Cold and Flu Supplement Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cold and Flu Supplement Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Cold and Flu Supplement Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Cold and Flu Supplement Sales Value Share by Application (2021-2026) Table 29. Global Cold and Flu Supplement Sales Value Share by Application (2027-2032) Table 30. Global Cold and Flu Supplement Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cold and Flu Supplement Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Cold and Flu Supplement Sales Value Share by Region (2021-2026) Table 33. Global Cold and Flu Supplement Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Cold and Flu Supplement Sales Value Share by Region (2027-2032) Table 35. Global Cold and Flu Supplement Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Cold and Flu Supplement Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Cold and Flu Supplement Sales Value Market Share by Country (2021-2026) Table 38. Global Cold and Flu Supplement Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Cold and Flu Supplement Sales Value Market Share by Country (2027-2032) Table 40. Pfizer Company Information Table 41. Pfizer Business Overview Table 42. Pfizer Cold and Flu Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Pfizer Cold and Flu Supplement Product Portfolio Table 44. Pfizer Recent Development Table 45. GlaxoSmithKline Company Information Table 46. GlaxoSmithKline Business Overview Table 47. GlaxoSmithKline Cold and Flu Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. GlaxoSmithKline Cold and Flu Supplement Product Portfolio Table 49. GlaxoSmithKline Recent Development Table 50. Wakunaga of America Company Information Table 51. Wakunaga of America Business Overview Table 52. Wakunaga of America Cold and Flu Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Wakunaga of America Cold and Flu Supplement Product Portfolio Table 54. Wakunaga of America Recent Development Table 55. The Vitamin Shoppe Company Information Table 56. The Vitamin Shoppe Business Overview Table 57. The Vitamin Shoppe Cold and Flu Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. The Vitamin Shoppe Cold and Flu Supplement Product Portfolio Table 59. The Vitamin Shoppe Recent Development Table 60. NOW Foods Company Information Table 61. NOW Foods Business Overview Table 62. NOW Foods Cold and Flu Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. NOW Foods Cold and Flu Supplement Product Portfolio Table 64. NOW Foods Recent Development Table 65. Nordic Naturals Company Information Table 66. Nordic Naturals Business Overview Table 67. Nordic Naturals Cold and Flu Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Nordic Naturals Cold and Flu Supplement Product Portfolio Table 69. Nordic Naturals Recent Development Table 70. Neurobiologix Company Information Table 71. Neurobiologix Business Overview Table 72. Neurobiologix Cold and Flu Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Neurobiologix Cold and Flu Supplement Product Portfolio Table 74. Neurobiologix Recent Development Table 75. Klaire Labs Company Information Table 76. Klaire Labs Business Overview Table 77. Klaire Labs Cold and Flu Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Klaire Labs Cold and Flu Supplement Product Portfolio Table 79. Klaire Labs Recent Development Table 80. Himalaya Global Holdings Company Information Table 81. Himalaya Global Holdings Business Overview Table 82. Himalaya Global Holdings Cold and Flu Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Himalaya Global Holdings Cold and Flu Supplement Product Portfolio Table 84. Himalaya Global Holdings Recent Development Table 85. Flora Company Information Table 86. Flora Business Overview Table 87. Flora Cold and Flu Supplement Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Flora Cold and Flu Supplement Product Portfolio Table 89. Flora Recent Development Table 90. FineVine Company Information Table 91. FineVine Business Overview Table 92. FineVine Cold and Flu Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. FineVine Cold and Flu Supplement Product Portfolio Table 94. FineVine Recent Development Table 95. Dr. Willmar Schwabe GmbH Company Information Table 96. Dr. Willmar Schwabe GmbH Business Overview Table 97. Dr. Willmar Schwabe GmbH Cold and Flu Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Dr. Willmar Schwabe GmbH Cold and Flu Supplement Product Portfolio Table 99. Dr. Willmar Schwabe GmbH Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Cold and Flu Supplement Product Image Figure 2. Global Cold and Flu Supplement Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cold and Flu Supplement Market Size (2021-2032) & (US$ Million) Figure 4. Global Cold and Flu Supplement Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Herbal Extracts Image Figure 8. Natural Molecules Image Figure 9. Vitamins and Minerals Image Figure 10. Others Image Figure 11. Global Cold and Flu Supplement Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Cold and Flu Supplement Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Cold and Flu Supplement Sales Value Share by Type (2021-2032) Figure 14. Online Image Figure 15. Offline Image Figure 16. Global Cold and Flu Supplement Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cold and Flu Supplement Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Cold and Flu Supplement Sales Value Share by Application (2021-2032) Figure 19. Global Cold and Flu Supplement Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Cold and Flu Supplement Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Cold and Flu Supplement Sales Value (2021-2032) & (US$ Million) Figure 22. North America Cold and Flu Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Cold and Flu Supplement Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Cold and Flu Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Cold and Flu Supplement Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Cold and Flu Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Cold and Flu Supplement Sales Value (2021-2032) & (US$ Million) Figure 28. South America Cold and Flu Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Cold and Flu Supplement Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Cold and Flu Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Cold and Flu Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Herbal Extracts
  • Natural Molecules
  • Vitamins and Minerals
  • Others
Applications
  • Online
  • Offline
Companies covered
  • Pfizer
  • GlaxoSmithKline
  • Wakunaga of America
  • The Vitamin Shoppe
  • NOW Foods
  • Nordic Naturals
  • Neurobiologix
  • Klaire Labs
  • Himalaya Global Holdings
  • Flora
  • FineVine
  • Dr. Willmar Schwabe GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cold and Flu Supplement Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cold and Flu Supplement Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cold and Flu Supplement Market Dynamics
  1. 2.1 Cold and Flu Supplement Industry Trends
  2. 2.2 Cold and Flu Supplement Industry Drivers
  3. 2.3 Cold and Flu Supplement Industry Opportunities and Challenges
  4. 2.4 Cold and Flu Supplement Industry Restraints
3 Cold and Flu Supplement Market by Company
  1. 3.1 Global Cold and Flu Supplement Company Revenue Ranking in 2025
  2. 3.2 Global Cold and Flu Supplement Revenue by Company (2021-2026)
  3. 3.3 Global Cold and Flu Supplement Company Ranking (2024-2026)
  4. 3.4 Global Cold and Flu Supplement Company Manufacturing Base and Headquarters
  5. 3.5 Global Cold and Flu Supplement Company Product Type and Application
  6. 3.6 Global Cold and Flu Supplement Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cold and Flu Supplement Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cold and Flu Supplement Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cold and Flu Supplement Market by Type
  1. 4.1 Cold and Flu Supplement Type Introduction
  2. 4.1.1 Herbal Extracts
  3. 4.1.2 Natural Molecules
  4. 4.1.3 Vitamins and Minerals
  5. 4.1.4 Others
  6. 4.2 Global Cold and Flu Supplement Sales Value by Type
  7. 4.2.1 Global Cold and Flu Supplement Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Cold and Flu Supplement Sales Value by Type (2021-2032)
  9. 4.2.3 Global Cold and Flu Supplement Sales Value Share by Type (2021-2032)
5 Cold and Flu Supplement Market by Application
  1. 5.1 Cold and Flu Supplement Application Introduction
  2. 5.1.1 Online
  3. 5.1.2 Offline
  4. 5.2 Global Cold and Flu Supplement Sales Value by Application
  5. 5.2.1 Global Cold and Flu Supplement Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Cold and Flu Supplement Sales Value by Application (2021-2032)
  7. 5.2.3 Global Cold and Flu Supplement Sales Value Share by Application (2021-2032)
6 Cold and Flu Supplement Regional Value Analysis
  1. 6.1 Global Cold and Flu Supplement Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cold and Flu Supplement Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cold and Flu Supplement Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cold and Flu Supplement Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cold and Flu Supplement Sales Value (2021-2032)
  7. 6.3.2 North America Cold and Flu Supplement Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cold and Flu Supplement Sales Value (2021-2032)
  10. 6.4.2 Europe Cold and Flu Supplement Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cold and Flu Supplement Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cold and Flu Supplement Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cold and Flu Supplement Sales Value (2021-2032)
  16. 6.6.2 South America Cold and Flu Supplement Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cold and Flu Supplement Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cold and Flu Supplement Sales Value Share by Country, 2025 VS 2032
7 Cold and Flu Supplement Country-level Value Analysis
  1. 7.1 Global Cold and Flu Supplement Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cold and Flu Supplement Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cold and Flu Supplement Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cold and Flu Supplement Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cold and Flu Supplement Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cold and Flu Supplement Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cold and Flu Supplement Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer
  2. 8.1.1 Pfizer Company Information
  3. 8.1.2 Pfizer Business Overview
  4. 8.1.3 Pfizer Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Cold and Flu Supplement Product Portfolio
  6. 8.1.5 Pfizer Recent Developments
  7. 8.2 GlaxoSmithKline
  8. 8.2.1 GlaxoSmithKline Company Information
  9. 8.2.2 GlaxoSmithKline Business Overview
  10. 8.2.3 GlaxoSmithKline Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GlaxoSmithKline Cold and Flu Supplement Product Portfolio
  12. 8.2.5 GlaxoSmithKline Recent Developments
  13. 8.3 Wakunaga of America
  14. 8.3.1 Wakunaga of America Company Information
  15. 8.3.2 Wakunaga of America Business Overview
  16. 8.3.3 Wakunaga of America Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Wakunaga of America Cold and Flu Supplement Product Portfolio
  18. 8.3.5 Wakunaga of America Recent Developments
  19. 8.4 The Vitamin Shoppe
  20. 8.4.1 The Vitamin Shoppe Company Information
  21. 8.4.2 The Vitamin Shoppe Business Overview
  22. 8.4.3 The Vitamin Shoppe Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  23. 8.4.4 The Vitamin Shoppe Cold and Flu Supplement Product Portfolio
  24. 8.4.5 The Vitamin Shoppe Recent Developments
  25. 8.5 NOW Foods
  26. 8.5.1 NOW Foods Company Information
  27. 8.5.2 NOW Foods Business Overview
  28. 8.5.3 NOW Foods Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  29. 8.5.4 NOW Foods Cold and Flu Supplement Product Portfolio
  30. 8.5.5 NOW Foods Recent Developments
  31. 8.6 Nordic Naturals
  32. 8.6.1 Nordic Naturals Company Information
  33. 8.6.2 Nordic Naturals Business Overview
  34. 8.6.3 Nordic Naturals Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Nordic Naturals Cold and Flu Supplement Product Portfolio
  36. 8.6.5 Nordic Naturals Recent Developments
  37. 8.7 Neurobiologix
  38. 8.7.1 Neurobiologix Company Information
  39. 8.7.2 Neurobiologix Business Overview
  40. 8.7.3 Neurobiologix Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Neurobiologix Cold and Flu Supplement Product Portfolio
  42. 8.7.5 Neurobiologix Recent Developments
  43. 8.8 Klaire Labs
  44. 8.8.1 Klaire Labs Company Information
  45. 8.8.2 Klaire Labs Business Overview
  46. 8.8.3 Klaire Labs Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Klaire Labs Cold and Flu Supplement Product Portfolio
  48. 8.8.5 Klaire Labs Recent Developments
  49. 8.9 Himalaya Global Holdings
  50. 8.9.1 Himalaya Global Holdings Company Information
  51. 8.9.2 Himalaya Global Holdings Business Overview
  52. 8.9.3 Himalaya Global Holdings Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Himalaya Global Holdings Cold and Flu Supplement Product Portfolio
  54. 8.9.5 Himalaya Global Holdings Recent Developments
  55. 8.10 Flora
  56. 8.10.1 Flora Company Information
  57. 8.10.2 Flora Business Overview
  58. 8.10.3 Flora Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Flora Cold and Flu Supplement Product Portfolio
  60. 8.10.5 Flora Recent Developments
  61. 8.11 FineVine
  62. 8.11.1 FineVine Company Information
  63. 8.11.2 FineVine Business Overview
  64. 8.11.3 FineVine Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  65. 8.11.4 FineVine Cold and Flu Supplement Product Portfolio
  66. 8.11.5 FineVine Recent Developments
  67. 8.12 Dr. Willmar Schwabe GmbH
  68. 8.12.1 Dr. Willmar Schwabe GmbH Company Information
  69. 8.12.2 Dr. Willmar Schwabe GmbH Business Overview
  70. 8.12.3 Dr. Willmar Schwabe GmbH Cold and Flu Supplement Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dr. Willmar Schwabe GmbH Cold and Flu Supplement Product Portfolio
  72. 8.12.5 Dr. Willmar Schwabe GmbH Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst